Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  CVS Health Corp    CVS

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Court Rules Two CVS Florida Pharmacies Can't Ship Pain Pills

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/22/2012 | 11:59pm CEST
   By John Kell 
   Of  
 

A U.S. appeals court said two CVS Caremark Corp. (>> CVS Caremark Corporation) pharmacies in Florida cannot fill prescriptions for certain controlled drugs related to a Drug Enforcement Administration move to halt such sales.

The decision lifted a temporary, administrative stay that was granted to CVS earlier this month, at the time allowing the pharmacies to keep dispensing controlled medications after an appeals court denied the chain's request for preliminary injunction.

The case stems from DEA action that was taken last month against two Sanford, Fla., CVS stores that were alleged to be among four pharmacy customers of drug distributor Cardinal Health Inc. (CAH) that dispensed the pain drug oxycodone based on bad prescriptions.

The U.S. Court of Appeals for the District of Columbia Circuit on Thursday ruled CVS had "not satisfied the stringent requirements for a stay pending appeal." The decision comes roughly a week after an appeals court said a Cardinal Health distribution hub in Florida can't ship prescription painkillers.

In a prepared statement, CVS said it was "disappointed with today's ruling by the court," saying the company had taken actions that have substantially reduced the amount of oxycodone dispensed at the two Florida pharmacies.

"We remain committed to working with the DEA to do everything we can to reduce prescription drug abuse," CVS said.

-By John Kell, Dow Jones Newswires; 212-416-2480; [email protected]

-Jon Kamp and Timothy Martin of The Wall Street Journal contributed to this article

Stocks mentioned in the article : CVS Caremark Corporation
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CVS HEALTH CORP
12:18a CVS HEALTH : Marsh closing pharmacies, including 2 in Anderson
04/28 CVS HEALTH CORP (NYSE : CVS) Releases Report On Prescription Drug Abuse
04/27 CVS HEALTH : To Hold First Quarter 2017 Conference Call
04/27 CVS HEALTH : Report Examines Public Perceptions of Opioid Epidemic, Drug Disposa..
04/26DJExpress Scripts Faces Tough Test -- WSJ
04/24 CVS : Improving Health Care Delivery and Fostering Innovation
04/22 Cherokee Nation sues opioid providers Cherokee Nation sues opioid wholesaler..
04/21 CVS HEALTH CORPORATION : To Hold First Quarter 2017 Conference Call
04/21 CVS HEALTH : expands better-for-you food lineup
04/20 Cherokee Nation sues opioid wholesalers, retailers for abuse
More news
Sector news : Drug Retailers - NEC
04/26 PayPal's profit, revenue beat on higher processing volumes
04/26DJANTHEM : Says ACA Payment Loss Could Cause 20% Premium Hike -- Update
04/26DJExpress Scripts Faces Tough Test -- WSJ
04/25DJEXPRESS SCRIPTS : Faces a Future Without Its Biggest Customer
04/24DJEXPRESS SCRIPTS : Says It Will Lose Anthem, Its Biggest Customer, in 2020
More sector news : Drug Retailers - NEC
News from SeekingAlpha
04/28 Tematica's Take On Trump's Tax Proposal
04/27 My Dividend Growth Portfolio - Q1 2017 Summary
04/26 The Best Of The Blue Chips (And The Worst)
04/25 Sixth Portfolio Review - 'The Accelerated Dividend Portfolio'
04/25 McKesson Remains Undervalued
Advertisement
Financials ($)
Sales 2017 184 255 M
EBIT 2017 10 131 M
Net income 2017 5 470 M
Debt 2017 24 914 M
Yield 2017 2,35%
P/E ratio 2017 15,51
P/E ratio 2018 13,88
EV / Sales 2017 0,60x
EV / Sales 2018 0,57x
Capitalization 85 391 M
More Financials
Chart CVS HEALTH CORP
Duration : Period :
CVS Health Corp Technical Analysis Chart | CVS | US1266501006 | 4-Traders
Full-screen chart
Technical analysis trends CVS HEALTH CORP
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 86,3 $
Spread / Average Target 4,7%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Larry J. Merlo President, CEO & Non-Independent Director
David Wyatt Dorman Non-Executive Chairman
Jonathan C. Roberts Chief Operating Officer & Executive Vice President
David M. Denton Chief Financial Officer & Executive Vice President
Troyen A. Brennan Chief Medical Officer & Executive Vice President
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CVS HEALTH CORP4.47%85 391
WALGREENS BOOTS ALLIAN..4.57%93 545
EXPRESS SCRIPTS HOLDIN..-10.83%36 407
MCKESSON CORPORATION-1.54%29 325
CARDINAL HEALTH INC0.86%22 899
AMERISOURCEBERGEN CORP..4.94%17 828
More Results